Skip to main content

Adjuvant S-1 plus endocrine therapy improves invasive DFS in ER+/HER2− breast cancer

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Adjuvant S-1 plus endocrine therapy improves invasive DFS in ER+/HER2− breast cancer

User login

Username

Password

Reset your password

concept	Lead	score
Breast Cancer	1	1

Specialty	Lead	score
Hematology-Oncology	1	1